Managing Anemia in Chemotherapy

A continuing medical education activity sponsored by NAMCP and AAMCN
This activity was held live at the 2007 Fall Managed Care Forum.

This activity is valid from March 5, 2008 to March 15, 2009.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Amgen

PLEASE CLICK HERE TO VIEW PRESENTATION


PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org.  A score of 70% must be achieved to receive continuing education credits.  You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Summary
Concerns about the risk of decreased survival and increased thromboembolism with erythropoiesis stimulating agents have developed in recent years. Updated guidelines for the use of these agents in cancer and new black box warnings have occurred as a result of these concerns.  The guidelines note that the available agents have similar efficacy and that evolving information about risks must be considered.

Objectives

  • Discuss the American Society of Clinical Oncology Guidelines for use of erthropoietins
  • Recognize the new recommendations (2007) for ESA therapy

Faculty: Nikolaos Touroutoglou, MD, PhD, FACP, Nevada Cancer Center

Disclosure:

Dr. Touroutoglou has nothing to disclose.

 

Accreditation & Designation

The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM.  Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA).  VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

  

This activity is supported by an educational grant from Amgen